Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2016

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share

	For the years ended December 31,
	2016			2015
Net loss	$	(12,974,799	)	$	(21,121,885	)
Net loss -Non-controlling interest		(400,847	)		(826,629	)
Net loss attributable to Heat Biologics, Inc.	$	(12,573,952	)	$	(20,295,256	)
Weighted-average number of common shares used in net loss per share attributable to common stockholders —basic and diluted		17,586,210			8,015,687
Net loss per share attributable to Heat Biologics, Inc —basic and diluted	$	(0.71	)	$	(2.53	)

Schedule of Potentially Dilutive Securities

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:

	For the years ended December 31,
	2016		2015
Outstanding stock options		1,136,753		1,214,686
Unvested restricted stock units		56,250		—
Outstanding common stock warrants		3,103,963		142,392